Cysteine biosynthesis in a fungus, Histoplasma capsulatum

Sabouraudia
|March 1, 1979
PubMed

Insights

Histoplasma capsulatum yeast cells require -SH compounds for growth due to inactive sulfite reductase. The Downs strain

Area of Science:

  • Medical Mycology
  • Biochemistry
  • Fungal Pathogenesis

Background:

  • Cysteine biosynthesis is essential for fungal growth.
  • Dimorphic fungi like Histoplasma capsulatum exhibit distinct morphological phases with potentially different metabolic requirements.
  • Understanding metabolic pathways in pathogenic fungi is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the cysteine biosynthesis pathway in different strains of Histoplasma capsulatum.
  • To identify the metabolic basis for auxotrophy in the yeast phase of H. capsulatum.
  • To characterize the regulation of sulfite reductase in H. capsulatum.

Main Methods:

  • Analysis of cysteine biosynthesis in multiple H. capsulatum strains.
  • Growth assays in the presence and absence of -SH compounds and amino acids.
  • Enzyme activity assays for sulfite reductase.
  • Polyacrylamide gel electrophoresis (PAGE) of cellular extracts.

Main Results:

  • Mycelial H. capsulatum cells are prototrophic, while most yeast cells are auxotrophic for -SH compounds.
  • The auxotrophy is linked to a lack of active sulfite reductase in the yeast phase.
  • The Downs strain's yeast phase has active sulfite reductase but a different metabolic block, allowing growth with serine.
  • Sulfite reductase in the Downs yeast form is repressed by cysteine, unlike the constitutive mycelial form.
  • A specific protein band associated with sulfite reductase activity was detected in yeast cells grown in minimal or serine media.

Conclusions:

  • A critical defect in sulfite reductase activity in the yeast phase explains the cysteine auxotrophy in most H. capsulatum strains.
  • The Downs strain presents a unique metabolic regulation of cysteine biosynthesis, with a distinct block and cysteine-mediated repression of sulfite reductase.
  • Differential expression and regulation of sulfite reductase between yeast and mycelial phases are key to understanding H. capsulatum's dimorphism and metabolic adaptability.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Sulfur Assimilation01:20

Sulfur Assimilation

Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to become...
Amino Acid Biosynthetic Pathways01:29

Amino Acid Biosynthetic Pathways

Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which provide...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...